Rare diseases and orphan drugs

被引：73

作者：

Aronson, JK ^{[1
]}

机构：

[1] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 61卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.2006.02617.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：243 / 245

页数：3

共 14 条

[1] 75 years of opioid research: the exciting but vain quest for the Holy Grail [J].

Corbett, AD ;

Henderson, G ;

McKnight, AT ;

Paterson, SJ .

BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 :S153-S162

[2]

Dooley CT, 1997, J PHARMACOL EXP THER, V283, P735

[3] Two decades of orphan product development [J].

Haffner, ME ;

Whitley, J ;

Moses, M .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) :821-825

[4] The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ [J].

Henderson, G ;

McKnight, AT .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (08) :293-300

[5] An analysis of 112 acute porphyric attacks in Cape Town, South Africa - Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity [J].

Hift, RJ ;

Meissner, PN .

MEDICINE, 2005, 84 (01) :48-60

[6] Orphan drug development is progressing too slowly [J].

Joppi, R ;

Bertele, V ;

Garattini, S .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) :355-360

[7] A review of alcohol clearance in humans [J].

Lands, WEM .

ALCOHOL, 1998, 15 (02) :147-160

[8] Orphan drugs: legal aspects, current situation [J].

Lavandeira, A .

HAEMOPHILIA, 2002, 8 (03) :194-198

[9] Orphan drugs and the NHS: should we value rarity? [J].

McCabe, C ;

Claxton, K ;

Tsuchiya, A .

BRITISH MEDICAL JOURNAL, 2005, 331 (7523) :1016-1019

[10]

MELNICK JL, 1954, AM J PUBLIC HEALTH, V44, P571

← 1 2 →